Brinzolamide/timolol

Drug Profile

Brinzolamide/timolol

Alternative Names: Azarga; Elazop; Timolol/brinzolamide

Latest Information Update: 12 Nov 2016

Price : $50

At a glance

  • Originator Alcon
  • Class Amino alcohols; Antiglaucomas; Morpholines; Propanolamines; Sulfonamides; Thiadiazoles; Thiazines
  • Mechanism of Action Beta-adrenergic receptor antagonists; Carbonic anhydrase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Glaucoma; Ocular hypertension

Most Recent Events

  • 06 Sep 2016 No recent reports on development identified - Phase-III for Glaucoma and Ocular hypertension in USA (Ophthalmic)
  • 17 Apr 2013 Launched for Glaucoma in Malaysia, Singapore, Thailand, Taiwan and South Korea (Ophthalmic) prior to April 2013
  • 17 Apr 2013 Launched for Ocular hypertension in Malaysia Singapore, Thailand, Taiwan and South Korea (Ophthalmic) prior to April 2013
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top